Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by TinTorontoon Nov 21, 2018 2:14pm
148 Views
Post# 29005998

RE:RE:RE:RE:RE:RE:RE:BRUCE SUGGESTS REVENUE FROM MEDICAL MJ

RE:RE:RE:RE:RE:RE:RE:BRUCE SUGGESTS REVENUE FROM MEDICAL MJWell, that was your debate.  Mine was that you were a fool not to see the bigger picture in the medical sector - not that patients only want Tweed products, but that you only want their transdermal patches, or other delivery method that they may hold the rights to.  And the income that will be generated from them.  

Or perhaps those 500 patients in long term care facilities, participating in clinical trials with Canopy and the Ontario Long Tern Care Association, who will then become the foundation for every other clinical trial out there.  Did you think they’d be setting up vape dens in the nursing homes or selecting strains for their patients? 

Do you think that insurance companies would rather have patients treated with safe alternatives to opioids?  No point in going on, you have your eye on short tern plays.  The insurance companies are loving this - they win here.  

Bullboard Posts